Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With Diabetes
Wolfgang C. Winkelmayer(Palo Alto University), Barry M. Brenner(Brigham and Women's Hospital)
Cited by 57
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States
|American Journal of Kidney Diseases|2021|727
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|708
Congenital Oligonephropathy and the Etiology of Adult Hypertension and Progressive Renal Injury
|American Journal of Kidney Diseases|1994|597